Oxford Gene Technology (OGT), provider of innovative genetics research and biomarker solutions to advance molecular medicine, will launch its new CytoSure™ Consortium Cancer +SNP array (4x180k) at the Cancer Cytogenomics Microarray Consortium (CCMC) and Cytogenomics Array Group (CAGdb) combined meeting in Chicago on the 5th- 7th August, booth 4. The new CytoSure™ Consortium Cancer +SNP […]
HOUSTON — Roche (SIX: RO, ROG; OTCQX: RHHBY) announced plans today at the AACC 2013 Clinical Lab Expo for the U.S. introduction of the cobas 8100 automated workflow series, an advanced system designed to automate many routine tasks to help diagnostic laboratories increase efficiency, reduce expenses and maximize patient safety. “This total lab automation solution […]
Washington, DC — SISCAPA Assay Technologies, Inc. (SAT) announced publication of a study in Clinical Chemistry demonstrating that a SISCAPA-MALDI-TOF assay for protein C inhibitor can help identify patients at risk for recurrence of prostate cancer after radiotherapy. The assay measures a proteotypic peptide of protein C inhibitor enriched from tryptic digests of patient serum […]
FREMONT, Calif.–Clinical laboratory staff now have a tool that combines routine and cardiac/STAT monitoring markers for patients without the need for separate QC. The Thermo Scientific MAS Omni•CARDIO controls consolidate routine cardiac markers including Troponin I and T, CK-MB, Myoglobin, NT-proBNP and BNP-32 with several new cardiac/STAT markers including Myeloperoxidase, hCG, D-Dimer and Procalcitonin. These […]
SEATTLE and HOUSTON – NanoString Technologies, Inc. (NASDAQ: NSTG), a provider of life science tools for translational research and molecular diagnostic products, today announced an Early Access Program for nCounter Elements™, a line of General Purpose Reagents (GPRs) developed specifically to meet the needs of translational research and clinical laboratories. nCounter Elements GPRs enable researchers […]
HATFIELD, Pa — Genisphere LLC has licensed its 3DNA® Signal Amplification technology to Chembio Diagnostics, Inc., a leader in point-of-care (“POC”) diagnostic tests for infectious diseases. Chembio plans to use the signal enhancing technology for its Dual Path Platform (“DPP®”) rapid diagnostic pipeline tests, with the goal of achieving detection limits unique to rapid immunoassays […]
LEXINGTON, Mass. — Quanterix Corporation, a leader in high definition diagnostics, delivering ultrasensitive single molecule measurement for the benefit of human health, today announced that they will be attending the AACC Annual Meeting and Clinical Lab Expo on July 28 – August 1, 2013 in Houston, Texas. Quanterix will be presenting research based on its […]
Danvers, MA – Cell Signaling Technology, Inc. (CST) of Danvers, MA, announced today that it has granted Cepheid, Inc., a worldwide non-exclusive license to CST patent rights relating to the detection of ALK gene rearrangements for the field of PCR (polymerase chain reaction) diagnostic testing. Cepheid will develop a test, which is intended to identify […]
Program will emphasize a combination of training in classical clinical chemistry and specialty areas
Houston –– Waters Corporation (NYSE:WAT) announced today sponsorship of a new, two-year, postdoctoral Clinical Chemistry Fellowship at the University of California, San Diego School of Medicine. Fellows will be trained in classical clinical chemistry, laboratory administration and research practices to prepare them for directorship positions at medical schools or hospital-based clinical chemistry laboratories. “Our mission […]
SUNNYVALE, Calif., — Cepheid (Nasdaq: CPHD) today announced it has received market authorization from the U.S. Food & Drug Administration (FDA) for its Xpert® MTB/RIF test. The review decision was based on the de novo 510(k) review process, which allows novel products without predicates to be down-classified and brought to market. Xpert MTB/RIF is designed […]
Pay Invoice
Latest Blogs
-
New Report Details Higher Education Science R&D Spending
February 27, 2026 3:23 pm
-
Single Use Leads Bioreactor Market Growth
December 30, 2025 6:04 pm
Sitemap
Your Data and Privacy
About Us
IBO (Instrument Business Outlook) is a twice-monthly newsletter aimed at providing decision-makers with the latest and most complete information available on the life science and analytical instrument industry, and lab product markets. IBO delivers the latest curated industry news, information and trends, as well as SDi data and analysis to deliver the maximum in industry insight with a minimum time investment for executives and investors.
